MSCI USA IMI Biotech Advance Index

The MSCI USA IMI Biotech Advance Index aims to represent the performance of a set of companies across large, mid and small cap representation in the US market, that are associated with research, development, and commercialization of products for treating a broad range of diseases and disorders.
Get in touch
Document downloads
Index code
753365
Index type
Equity
Benchmark administrator
--
Div Yld (%)
0.88
P/E
115.27
P/E Fwd
42.00
P/BV
5.09
Number of constituents
97
Index Market Cap
$1.95 T
Largest constituent Market Cap
$219.60 B
Smallest constituent Market Cap
$641.54 M
Average constituent Market Cap
$20.14 B
Median constituent Market Cap
$5.68 B
Does this benchmark pursue ESG objectives?
No
Data as of April 30, 2025 

Want to learn more about MSCI indexes?
Get in touch.

Contact us